Loading...
•
Dec 31, 2025
Thermo Fisher Q4 2025 Earnings Report
Thermo Fisher reported strong Q4 2025 results with revenue and earnings growth driven by new product launches and strategic investments.
Key Takeaways
Thermo Fisher delivered a solid Q4 2025, reporting higher revenue and earnings per share, with strong net income. The company advanced its growth strategy through major product launches, AI collaborations, and strategic acquisitions.
Revenue by Segment
Forward Guidance
2026 guidance will be shared during the earnings call; the company enters the year from a position of strength with a clear strategic roadmap.
Positive Outlook
- Strong execution of growth strategy
- Strategic AI collaboration with OpenAI
- FDA approval for new diagnostics tool
- Launch of high-impact new instruments
- Expanded bioprocess capabilities in Asia
Challenges Ahead
- Adjusted operating margin slightly declined YoY
- R&D expenses remained flat
- Currency translation continues to impact results
- Full-year free cash flow declined from previous year
- Operating cash flow lower than FY2024
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...